![](/img/cover-not-exists.png)
Cost-effectiveness of ceftolozane/tazobactam plus metronidazole versus piperacillin/tazobactam as initial empiric therapy for the treatment of complicated intra-abdominal infections based on pathogen distributions drawn from national surveillance data in the United States
Prabhu, Vimalanand S., Solomkin, Joseph S., Medic, Goran, Foo, Jason, Borse, Rebekah H., Kauf, Teresa, Miller, Benjamin, Sen, Shuvayu S., Basu, AnirbanVolume:
6
Language:
english
Journal:
Antimicrobial Resistance & Infection Control
DOI:
10.1186/s13756-017-0264-2
Date:
December, 2017
File:
PDF, 753 KB
english, 2017